Regulation of the p53 pathway by Ras, the plot thickens

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1471, Issue 2, 2001, Pages

  McMahon, Martin ^a   Woods, Douglas ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cell cycle inhibitor; p53; Raf; Ras; Senescence

Indexed keywords

GUANOSINE TRIPHOSPHATASE; PROTEIN MDM2; PROTEIN P53; RAF PROTEIN; RAS PROTEIN;

CELL CULTURE; CELL CYCLE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INDUCTION; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN INDUCTION; REGULATORY MECHANISM; SENESCENCE; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 0035951481     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-419X(00)00027-5     Document Type: Review

References (86)

1. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions
2. Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter
3. Enhanced phosphorylation of p53 by ATM in response to DNA damage
4. p14ARF links the tumour suppressors RB and p53
5. ras oncogenes in human cancer: A review
6. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27
7. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
8. The biology of replicative senescence
9. Cancer, aging and cellular senescence
10. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization
11. Cooperative effects of genes controlling the G[2]/M checkpoint
12. The E2F transcription factor is a cellular target for the RB protein
13. Essential role for oncogenic Ras in tumour maintenance
14. The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation
15. ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes
16. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor
17. Geranylgeranylated RhoB mediates suppression of human tumor cell growth by farnesyltransferase inhibitors
18. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes
19. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53
20. PML is induced by oncogenic ras and promotes premature senescence
21. Tripping the switch fantastic: How a protein kinase cascade can convert graded inputs into switch-like outputs
22. In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes
23. Mdm2 association with p53 targets its ubiquitination
24. A role for E2F1 in Ras activation of p21(WAF1/CIP1) transcription
25. Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases
26. Creation of human tumour cells with defined genetic elements
27. The hallmarks of cancer
28. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F
29. Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest
30. Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1
31. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
32. Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1
33. Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent-kinase-independent mechanism
34. Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, ras transformation, and tumorigenesis
35. K-ras is an essential gene in the mouse with partial functional overlap with N-ras
36. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
37. Ectopic expression of activated Ras1 induces hyperplastic growth and increased cell death in Drosophila imaginal tissues
38. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors
39. Ras induces p21Cip1/Waf1 cyclin kinase inhibitor transcriptionally through Sp1-binding sites
40. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes
41. New functional activities for the p21 family of CDK inhibitors
42. The discovery of potent cRaf1 kinase inhibitors
43. Phosphorylation of p53 serine 15 increases interaction with CBP
44. The retinoblastoma protein is linked to the activation of Ras
45. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling
46. Ras versus cyclin-dependent kinase inhibitors
47. Cooperating oncogenes converge to regulate cyclin/cdk complexes
48. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b)
49. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
50. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1
51. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
52. The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression
53. Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein
54. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins
55. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1
56. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras
57. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
58. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein
59. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1)
60. Ras1 promotes cellular growth in the Drosophila wing
61. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway
62. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
63. Raf-1-induced cell cycle arrest in LNCaP human prostate cancer cells
64. Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small-cell lung cancer cells
65. Activated Raf-1 causes growth arrest in human small cell lung cancer cells
66. Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation
67. ARF
68. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
69. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
70. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1
71. Induction of Mdm2 and enhancement of cell survival by bFGF
72. ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation
73. The ARF/p53 pathway
74. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
75. Developmental control by the Drosophila EGF receptor homolog DER
76. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras
77. Genetics of RAS signaling in C. elegans
78. Signaling specificity: The RTK/RAS/MAP kinase pathway in metazoans
79. p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential
80. Role of PML in cell growth and the retinoic acid pathway
81. Nucleolar Arf sequesters Mdm2 and activates p53
82. Dormant tumor-suppressor pathways in tumors
83. Regulation of the cell cycle machinery by oncogenic ras
84. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1
85. Keratinocytes blocked in phorbol ester-responsive early stage of terminal differentiation by sarcoma viruses
86. Senescence of human fibroblasts induced by oncogenic